Overview

A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
A study of 3 doses of Progenta versus placebo versus Lucron Depot for treatment of leiomyomata.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Leuprolide